Woman In Brown Suede Peacoat Reading A Book

Recent Healthcare Technology

Recent Healthcare Technology

One key and recent healthcare technology is CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats), a gene-editing tool that allows scientists to modify an organism’s DNA with high precision. CRISPR has revolutionized the field of genetics and has the potential to cure genetic diseases, such as cystic fibrosis and sickle cell anemia, by correcting faulty genes. However, its use raises significant moral and ethical concerns, particularly around human germline editing and gene enhancement. MLA.

Recent Healthcare Technology

ARE YOU LOOKING FOR THIS ANSWER?

CLICK HERE TO ORDER THE ASSIGNMENT.

Recent Healthcare Technology

Two Key Moral Problems:
1. Human Germline Editing: CRISPR can be used to modify the genes of human embryos, leading to permanent genetic changes that will be passed down to future generations. This creates ethical concerns about unforeseen consequences, such as unintended mutations, which could affect not only the individual but their descendants. Moreover, it raises questions about whether humans should interfere with the natural genetic makeup of future generations, a form of playing God.

2. Gene Enhancement: The technology also has the potential for non-therapeutic uses, such as enhancing intelligence, physical abilities, or appearance, leading to concerns about inequality and access. If CRISPR were used for enhancement, it could create a genetic divide between those who can afford such enhancements and those who cannot, exacerbating social inequalities and creating a new form of genetic discrimination.

Recent Healthcare Technology

 Moral Guidelines:
In my view, the proper moral guidelines should emphasize safety, equity, and respect for human dignity. CRISPR should be limited to therapeutic uses aimed at curing serious diseases, and rigorous safety protocols should be in place to prevent unintended consequences. Germline editing should be approached with extreme caution and only used in cases where the benefits clearly outweigh the risks, such as eliminating a life-threatening genetic disorder. Non-therapeutic enhancements should be prohibited to avoid creating a societal divide and ensuring equal access to medical benefits.

 Utilitarian Perspective:
A utilitarian would likely support the use of CRISPR if it leads to the greatest overall good. From this viewpoint, the benefits of curing genetic diseases, improving public health, and reducing suffering could justify the use of CRISPR, even if there are risks involved. However, a utilitarian would also be concerned about the societal impact of gene enhancement, as it could lead to widespread inequality and social harm. The focus would be on maximizing collective well-being, which may mean supporting CRISPR for therapeutic purposes but opposing its use for enhancement.

Recent Healthcare Technology

Ethical Egoist Perspective:
An ethical egoist would focus on the self-interest of the individual, supporting the use of CRISPR if it benefits them personally, regardless of the broader societal implications. If a person believes that gene editing will improve their own life or the lives of their descendants, an egoist might support its use, even for enhancement. The ethical egoist’s concern would be less about social inequality and more about personal gain and self-advancement.

Global Ethical Beliefs:
Global ethical perspectives on CRISPR vary. In countries with a strong emphasis on collective well-being and social harmony (e.g., some Eastern cultures), there may be more caution and resistance to germline editing and enhancement, aligning with a utilitarian approach that prioritizes the good of society. In contrast, cultures that emphasize individual autonomy (e.g., the U.S.) might be more open to genetic enhancements, aligning more with an ethical egoist perspective. However, concerns about safety, inequality, and unintended consequences are likely to resonate across diverse ethical beliefs, leading to a shared cautious approach regarding the limits of CRISPR technology.

Share your love

Newsletter Updates

Enter your email address below and subscribe to our newsletter